IconOVir
PrivateLast Round
Series B
Jun 6, 2023
Total Funding Raised
$97.2M
Company Overview
IconOVir Bio is a biotechnology company focused on developing advanced oncolytic virus therapies aimed at enhancing cancer treatment through personalized approaches.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IconOVir Comps
Public and private peers based on sector, stage, and business model.
IconOVir Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 6, 2023 | ||||
| Series A | Jan 5, 2021 |
Key People
Founding team and executive leadership
IconOVir Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Two River Group | Series A |
| GV | Series A |
| Vida Ventures | Series A |
| Bellco Capital | Series A |
| Logos Capital | Series A |
| Polaris Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 21, 2025
Sold oncolytic virus asset for $4 million in stock.
IconOVir Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about IconOVir's valuation, stock price, and market status.
